Please use this identifier to cite or link to this item: http://nopr.niscair.res.in/handle/123456789/42846
Title: Antitumor potential of herbomineral formulation against breast cancer: Involvement of inflammation and oxidative stress
Authors: Bakrania, Anita K
Nakka, Surender
Variya, Bhavesh C
Shah, Prabodh V
Patel, Snehal S
Keywords: Adhatoda vasica;Antiangiogenic;Anticancer activity;Anti-inflammatory;Antioxidant;Ayurvedic;Boerhavia diffusa;Cruel capsule;Dimethylbenz[a]anthracene;Glycyrrhiza glabra;Mammary carcinogenesis;Moringa pterygosperma;Piper nigrum;Syzygium aromaticum;Tinospora cordifolia;Tumor
Issue Date: Oct-2017
Publisher: NISCAIR-CSIR, India
Abstract: Breast cancer, the most frequently diagnosed cancer is a leading cause of death in females worldwide. Here, we evaluated the effect of herbomineral formulation [Cruel capsule (CC), an ayurvedic proprietary medicine] on DMBA-induced mammary carcinogenesis in rat. Fifty days postpartum female Sprague-Dawley rats were grouped into control, control treated with herbomineral formulation (30 mg/kg/day, p.o.), disease control, disease treated with herbomineral formulation (30mg/kg/day,p.o.). Breast cancer was induced by dimethylbenz[a]anthracene (DMBA) (60 mg/kg, p.o). Animals were palpated twice weekly for the incidence and tumor size. After 48 h of last dose, blood was collected for estimations of LDH, GGT, C-RP & ESR. Animals were sacrificed and tumors isolated for histopathological examinations and antioxidant studies. Treatment with formulation showed significantly decreased LDH, GGT, CRP & ESR compared to disease control group. Histopathological examinations showed hyperplastic and well demarcated tubular inflammation which was improved by treatment with the formulation. Treatment also showed significant decrease in MDA and increase in GSH and SOD levels in breast homogenate as compared to the disease control group. From the present investigations, we can conclude that the herbomineral formulation (CC) inhibits the tumor progression and the mechanism for the chemopreventive potential of formulation may be due to its anti-inflammatory, antiangiogenic and antioxidant potential.
Page(s): 680-687
URI: http://nopr.niscair.res.in/handle/123456789/42846
ISSN: 0975-1009 (Online); 0019-5189 (Print)
Appears in Collections:IJEB Vol.55(10) [October 2017]

Files in This Item:
File Description SizeFormat 
IJEB 55(10) 680-687.pdf216.95 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.